大洋生物:关于使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告

Group 1 - The company announced the redemption of a large deposit certificate from Hangzhou Bank, amounting to 10 million yuan, on January 6, 2026, yielding a profit of 253,600 yuan [2] - On the same day, the company reinvested the idle raised funds of 10 million yuan into a similar two-year principal-protected floating income product, with an expected annualized return of 2.55% [2]

DAYANG BIOTECH-大洋生物:关于使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告 - Reportify